Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
GLP-1 RAs are currently indicated for the treatment of diabetes with cardiovascular disease to improve glycemic control, in addition to weight loss management
Not yet in formal clinical trials
This single treatment can be done awake or at the time of other surgery and you are back to regularly activity within just a day or two
These medications are preferred first-line agents due to their safety profiles and generally favorable balance of efficacy and tolerability
GLP-1 and GIP agonists bind to and activate GLP-1 and GIP receptors to increase glucose dependent insulin secretion from the pancreas, suppress glucagon secretion and slow gastric emptying
US$ 29.76
US$ 25.17
US$ 28.57
